Details of the Drug

General Information of Drug (ID: DMM3I1P)

• Drug Name: 1,2-bis(3-fluorophenyl)ethane-1,2-dione
• Synonyms: 1,2-bis(3-fluorophenyl)ethane-1,2-dione; CHEMBL242067; 3,3'-Difluorobenzil; SCHEMBL3169331; NIOZEPOIIGVTTO-UHFFFAOYSA-N; BDBM50209414

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

• Drug Type: Small molecular drug
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 246.21
  Logarithm of the Partition Coefficient (xlogp); 3.6
  Rotatable Bond Count (rotbonds); 3
  Hydrogen Bond Donor Count (hbonddonor); 0
  Hydrogen Bond Acceptor Count (hbondacc); 4
• Chemical Identifiers:
  Formula: C14H8F2O2
  IUPAC Name: 1,2-bis(3-fluorophenyl)ethane-1,2-dione
  Canonical SMILES: C1=CC(=CC(=C1)F)C(=O)C(=O)C2=CC(=CC=C2)F
  InChI: InChI=1S/C14H8F2O2/c15-11-5-1-3-9(7-11)13(17)14(18)10-4-2-6-12(16)8-10/h1-8H
  InChIKey: NIOZEPOIIGVTTO-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 22574214
  CAS Number: 70028-89-6
  TTD ID: D0Y6RZ

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Liver carboxylesterase (CES1)	TTMF541	EST1_HUMAN	Inhibitor	[1]

Molecular Expression Atlas of This Drug

• The Studied Disease: Discovery agent
• ICD Disease Classification: N.A.

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Liver carboxylesterase (CES1)	DTT	CES1	3.82E-08	1.86	1.9

References

• [1] Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils. Bioorg Med Chem. 2007 Jun 1;15(11):3801-17.